Kristen E. Shannon

Heterozygous Germ Line <i>hCHK2</i> Mutations in Li-Fraumeni Syndrome

Daphne W. Bell, Jennifer M. Varley, Tara E. Szydlo et al. · Science · 1999 · 899 citations

Anti-metastatic properties of RGD-peptidomimetic agents S137 and S247

Kristen E. Shannon, Jeffery L. Keene, Steven L. Settle et al. · Clinical & Experimental Metastasis · 2004 · 70 citations

Medicine, Peptoid, Anti-metastatic Properties +4

Germline mutations in PTEN are an infrequent cause of genetic predisposition to breast cancer

Michael G. FitzGerald, Deborah J. Marsh, Doke C.R. Wahrer et al. · Oncogene · 1998 · 68 citations

Breast Oncology, Somatic Variant, Medicine +10

Heterozygous Germline <i>ATM</i> Mutations Do Not Contribute to Radiation-Associated Malignancies After Hodgkin's Disease

Kim E. Nichols, Seth Levitz, Kristen E. Shannon et al. · Journal of Clinical Oncology · 1999 · 66 citations

Identification of 4-(Aminomethyl)-6-(trifluoromethyl)-2-(phenoxy)pyridine Derivatives as Potent, Selective, and Orally Efficacious Inhibitors of the Copper-Dependent Amine Oxidase, Lysyl Oxidase-Like 2 (LOXL2)

Martin W. Rowbottom, Gretchen Bain, Imelda Calderon et al. · Journal of Medicinal Chemistry · 2017 · 65 citations · Full text

Initial Hit 2, Pharmacotherapy, Chemical Biology +21